Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B Patients

Summary

There are chronic hepatitis B patients with poor antiviral efficacy of entecavir in clinical practice. Tenofovir or interferon alfa is the optimal choice right now. The aim of this study is to investigate the therapeutic effect of using tenofovir of interferon alfa in these patients.

Timeline

Start

2018-11-15

Primary completion

2021-09-30

Completion

2021-12-31

Drugs

Indications